Multiple viral enzymes and replication processes

Multiple viral enzymes and replication processes refer to the diverse set of molecular targets within a virus's life cycle, including entry, uncoating, genome replication, assembly, and egress (Source: Nature Reviews Microbiology). This category encompasses various enzymes such as RNA-dependent RNA polymerases (RdRp), proteases, and integrases, which are essential for the propagation of viruses like SARS-CoV-2, HIV, and Hepatitis C (Source: NIH, StatPearls). Antiviral drugs often target these specific enzymes to inhibit viral replication; for example, Remdesivir targets the RdRp, while Ritonavir inhibits viral proteases (Source: PubChem). Because of the high mutation rates in many viruses, targeting multiple enzymes or processes is a common strategy to prevent the emergence of drug-resistant strains. This grouping is a conceptual framework for antiviral therapy rather than a single, specific protein target. Consequently, it is often used in the context of broad-spectrum antiviral development and multi-drug regimens like Highly Active Antiretroviral Therapy (Source: PubMed).

Other names

Viral replication machineryViral life cycle targetsBroad-spectrum antiviral targetsViral replication cycle

Inhibition of various viral enzymes such as polymerases, proteases, and integrases to disrupt the viral life cycle and prevent replication.